Emergency Echocardiography in Sepsis
Key facts
- Who runs it
- University Hospital, Limoges
- Where
- France10 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 312 people enrolled
- Started
- 23 Jul 2021
- Ended
- 15 Apr 2025
- Type of study
- Interventional, 2 groups
- Treatments tested
- early transthoracic echocardiography
- standards of care
- Record updated
- 21 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients admitted to the ED
- Age ≥ 18 years and affiliation to Social Security
- With sepsis (Sepsis-3 definition):; Clinically suspected or documented acute infection; AND a quick score Sequential Organ Failure Assessment (qSOFA) ≥ 2 points with:
- Systolic blood pressure ≤ 100 mmHg (1 point) requiring fluid loading
- AND encephalopathy (1 point) OR respiratory rate ≥ 22 cpm (1 point) AND a systolic blood pressure ≤ 100 mmHg after 500 mL of crystalloid vascular filling - Informed consent
Who cannot take part
- Decision to limit care or moribund status
- Pregnancy or breast feeding
- Subject under juridical protection
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Acute circulatory failure that combines hypovolemia, vasoplegia and cardiac dysfunction plays a major role in the development of sepsis-related organ dysfunction. Pathophysiological mechanisms are multiple and complex. The objective of the GENESIS study is to determine the impact of early haemodynamic assessment using echocardiography in association with a therapeutic algorithm (intervention arm), when compared with standard of care based on the current Surviving Sepsis Campaign (SSC) recommendations (control arm), on the development of organ dysfunctions in patients admitted to the Emergency Department for sepsis or septic shock.
The 2 groups in the trial
- Intervention armTreatment being tested
Assessment using an early transthoracic echocardiography (after 500 mL of fluids) to identify the hemodynamic profile responsible for the acute circulatory failure associated with sepsis / septic shock and to guide ongoing treatment (therapeutic algorithm) and monitor its efficacy and tolerance.
Treatment: early transthoracic echocardiography
- Control armOther group
Conventional management according to current standards of care based on SSC recommendations, including a standardized fluid resuscitation of 30 mL/kg.
Treatment: standards of care
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of Early Haemodynamic Assessment by Echocardiography on Organ Dysfunction of Patients Admitted in the Emergency Department for Sepsis or Septic Shock
- Publications
- Record updated
- 21 November 2025